Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data.

MLA

Smith, Grace L., et al. “Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 36, no. 24, Aug. 2018, pp. 2565–66. EBSCOhost, https://doi.org/10.1200/JCO.2018.78.5428.

APA

Smith, G. L., Das, P., Herman, J. M., Koay, E. J., Koong, A. C., Grossberg, A., & Ludmir, E. (2018). Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36(24), 2565–2566. https://doi.org/10.1200/JCO.2018.78.5428

Chicago

Smith, Grace L, Prajnan Das, Joseph M Herman, Eugene J Koay, Albert C Koong, Aaron Grossberg, and Ethan Ludmir. 2018. “Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 36 (24): 2565–66. doi:10.1200/JCO.2018.78.5428.